# NaxaAS-6mg
Cuperic combats mold and mildew primarily through contact killing and cellular disruption. When fungi interact with copper, the metal releases Cu⁺ and Cu²⁺ ions that destabilize cell membranes, induce oxidative stress, denature proteins, and interfere with DNA replication, effectively preventing spore germination.

Here are the three complete source files structured for your repository to implement the clinical protocols, tracking metrics, and bioavailability calculations.

* * * * *

1\. `CLINICAL_FRAMEWORK.md`
---------------------------

```
# Specialized Cupric Protocol & Integration Framework

This document outlines the clinical protocols, regulatory pathways, and hospital integration workflows for utilizing unmixed, transparently sourced cupric compounds.

## 1. Clinical Delivery & Monitoring Matrix

Systemic absorption of therapeutic copper must be meticulously restricted below established Tolerable Upper Intake Levels (UL) to mitigate hepatic stress, lipid peroxidation, and systemic organ toxicity.

### Core Safety Monitoring Schedule
* **Serum Copper:** Baseline collection required; weekly intra-treatment screening; target therapeutic threshold of 70--140 µg/dL.
* **Ceruloplasmin:** Baseline collection required; bi-weekly intra-treatment monitoring; target maintenance range of 20--50 mg/dL.
* **Liver Function Tests (ALT/AST):** Baseline range validation; bi-weekly tracking; immediate treatment cessation required if markers exceed 2x Upper Limit of Normal (ULN).

---

## 2. Regulatory Compliance & Patient Disclosure

### Single-Patient Expanded Access (Compassionate Use)
Prescriptions utilizing novel, white-labeled compounding protocols for home-use must be formally processed through the FDA Expanded Access pathway.
* **Regulatory Form:** Submit Form FDA 3926 for individual patient Investigational New Drug (IND) authorization.
* **Institutional Review Board (IRB) Process:** Section 10.b of Form FDA 3926 permits a waiver request to allow rapid single-chairperson concurrence instead of full institutional panel reviews.
* **Emergency Filing Windows:** Emergency treatments initiated prior to formal submission require complete documentation delivery to the FDA within 15 working days.

### Patient Informed Consent Standard
> **VOLUNTARY PATIENT DISCLOSURE & INFORMED CONSENT**
>
> 1\. **Substance Clarification:** The patient recognizes that this protocol involves unmixed, high-purity Cupric ($Cu^{2+}$) compounds targeting cellular membrane stability without additive blending.
> 2\. **Associated Risks:** Potential clinical complications include temporary gastrointestinal shifts, localized irritation, or elevated serum copper profiles necessitating metabolic tracking.
> 3\. **Voluntary Acknowledgment:** I verify that I have reviewed the clinical protocol, understand its investigational status, and consent freely to this treatment plan.
>
> Patient Signature: ___________________________ Date: _______________
> Attending Physician Signature: ___________________________ Date: _______________

---

## 3. Insurance Claims Architecture (CMS-1500)

All clinic-level evaluations and therapeutic compound administrations must follow standard formatting guidelines defined under Chapter 26 of the Medicare Claims Processing Manual.

* **Item 1:** Check "Medicare" or appropriate commercial payer box.
* **Item 1a:** Insured's Unique Identification Number.
* **Item 14:** Date of Current Illness/Injury accompanied by the initial treatment qualifier.
* **Item 21 (ICD-10-CM Coding):**
  * **Line A:** `B49` (Unspecified mycosis / systemic fungal manifestation)
  * **Line B:** `E83.01` (Copper overload/metabolic monitoring context if applicable)
* **Item 24D (CPT/HCPCS Codes):**
  * **Therapeutic Infusion:** CPT code for initial intravenous infusion up to 1 hour.
  * **Evaluation & Management:** Appropriate E/M code for an established outpatient clinic visit.
* **Item 32:** Document the full name, physical address, 9-digit zip code, and National Provider Identifier (NPI) of the administering university hospital facility.

```

* * * * *

2\. `SAFETY_MONITORING.tsv`
---------------------------

```
Metric	Baseline_Requirement	Intra_Treatment_Monitoring	Post_Treatment_Target
Serum_Copper	Prior_to_1st_dose	Weekly_during_active_therapy	70-140_ug/dL
Ceruloplasmin	Prior_to_1st_dose	Every_2_weeks	20-50_mg/dL
Liver_Function_ALT_AST	Document_normal_range	Bi-weekly_discontinue_if_gt_2x_ULN	Baseline_levels

```

* * * * *

3\. `BIOAVAILABILITY_CALC.py`
-----------------------------

```
"""
Cupric Bioavailability and Total Daily Intake (TDI) Calculator.
Enforces metabolic boundaries to prevent systemic copper toxicity.
"""

def calculate_total_daily_intake(c_oral: float, v_oral: float, alpha: float, c_iv: float, v_iv: float) -> float:
    """
    Calculates the Total Daily Intake (TDI) of Cu2+ ions in milligrams.

    Formula:
    TDI = (c_oral * v_oral * alpha) + (c_iv * v_iv)

    Parameters:
    c_oral (float): Concentration of oral copper solution (mg/mL).
    v_oral (float): Daily volume of oral solution administered (mL).
    alpha  (float): Gastrointestinal absorption coefficient (typically 0.3 to 0.4).
    c_iv   (float): Concentration of intravenous copper solution (mg/mL).
    v_iv   (float): Daily volume of intravenous solution administered (mL).

    Returns:
    float: Total systemic copper load delivered per 24-hour cycle.
    """
    oral_component = c_oral * v_oral * alpha
    iv_component = c_iv * v_iv
    return oral_component + iv_component

def verify_safety_threshold(tdi: float, upper_limit: float = 10.0) -> bool:
    """
    Cross-checks calculated total daily intake against safe physiological caps.
    Default upper limit is set to 10.0 mg/day (Standard Adult UL).
    """
    if tdi > upper_limit:
        return False
    return True

if __name__ == "__main__":
    # Example operational scenario configuration
    ORAL_CONC = 0.5    # 0.5 mg/mL
    ORAL_VOL = 10.0    # 10 mL
    GI_ABSORP = 0.35   # 35% estimated GI uptake

    IV_CONC = 0.1      # 0.1 mg/mL
    IV_VOL = 20.0      # 20 mL

    MAX_SAFE_UL = 10.0 # 10 mg/day max limit

    systemic_load = calculate_total_daily_intake(ORAL_CONC, ORAL_VOL, GI_ABSORP, IV_CONC, IV_VOL)
    is_safe = verify_safety_threshold(systemic_load, MAX_SAFE_UL)

    print(f"Calculated Systemic Copper Intake: {systemic_load:.2f} mg/day")
    print(f"Protocol Safety Status: {'APPROVED' if is_safe else 'ALERT: EXCEEDS LIMIT'}")

```

* * * * *
